Delivery Order SPE2DB24D3014-SPE2DB25FKUNB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $14,433.09. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,387.60. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of September 22, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $7,835.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on May 30, 2025, with an ultimate completion date of June 2, 2025. The award was competitively procured with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $24,953.82 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a $23,545.12 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 28, 2025, and fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets in quantities of 8 units. This is a firm fixed-price delivery order valued at $27,389.85, with an ultimate completion date of July 15, 2025. The award was made through competitive procedures with no set-aside designation. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $17,461.79 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed price contract type. This non-competitive delivery order was issued on June 16, 2025, with an ultimate completion date of June 17, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,177.74 on August 29, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 2, 2025, with performance executed from the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $10,274.35 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count). The contract utilizes firm fixed-price terms and is classified as a non-competitive, non-set-aside award. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order represents a child contract under...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUNBDelivery Order
The Defense Logistics Agency awarded a $8,880.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging). The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of September 3, 2025. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier to federal medical procurement systems, particularly for military and veteran healthcare programs. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries through DLA, encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. NURTEC ODT is a migraine treatment medication, reflecting AmerisourceBergen's role in supplying specialized neurological and pain management pharmaceuticals to support Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 9/2/25 |